Cathy Nobil-Dutton did all the right things to protect her health, but a uterine cancer diagnosis showed her life doesn’t always go as expected.

by Cathy Nobil-Dutton

Young adults often ignore telltale signs of colorectal cancer, and more evidence supports active surveillance for low-risk prostate cancer.

by Marci A. Landsmann

Aspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.

by Sandra Gordon

New immunotherapy approved for small cell lung cancer, and researchers investigate using urine tests to detect cancer.

by Kevin McLaughlin

Disparities in cancer outcomes shrink but persist, and FDA approval increases access to HPV screening.

by Eric Fitzsimmons

New research fuels progress in cancer survival, prevention and side effect management.

People may be able to wait longer between colonoscopies, and a trial evaluates a less invasive option for treating prostate cancer.

by Thomas Celona

Patients should consider the potential risks, and not just rewards, before changing providers.

by Kyle Bagenstose

Updated recommendation lowers age for breast cancer screening, and laboratory tests will undergo greater FDA oversight.

by Marci A. Landsmann

Supplemental breast screenings are not covered by Medicare, and researchers develop a treatment option for a form of eye cancer.

by Kevin McLaughlin